# Comparative Study of Human Immunodeficiency Virus Negative Host Talaromyces Between Voriconazole and Amphotericin Sequential Itraconazole Therapy

> **NCT03827278** · NA · UNKNOWN · sponsor: **Guangxi Medical University** · enrollment: 200 (estimated)

## Conditions studied

- Talaromyces in Human Immunodeficiency Virus Negative
- To Compare Voriconazole and Amphotericin Sequential Itraconazole Therapy
- To Dynamically Monitor the Anti-Interferon-γ Autoantibodies

## Interventions

- **DRUG:** Voriconazole

## Key facts

- **NCT ID:** NCT03827278
- **Lead sponsor:** Guangxi Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-12-30
- **Primary completion:** 2021-12-30
- **Final completion:** 2021-12-30
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2019-02-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03827278

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03827278, "Comparative Study of Human Immunodeficiency Virus Negative Host Talaromyces Between Voriconazole and Amphotericin Sequential Itraconazole Therapy". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT03827278. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*